Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of platycodon saponin d in the preparation of antitumor drugs

A technology of tumor drug, platycodon saponin, applied in the medical field, can solve the problem of destroying the human immune system and achieve the effect of reducing adverse reactions

Inactive Publication Date: 2019-02-15
SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main treatment for osteosarcoma is surgery plus postoperative chemotherapy, but chemotherapy drugs often have strong side effects, and at the same time damage the body's immune system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of platycodon saponin d in the preparation of antitumor drugs
  • Application of platycodon saponin d in the preparation of antitumor drugs
  • Application of platycodon saponin d in the preparation of antitumor drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Example 1: Implementation steps of the effect of platycodon saponin D on the viability of osteosarcoma cells and human osteoblast hFOB cells.

[0012] The osteosarcoma cell line Saos2-lung was cultured in vitro, which is a subpopulation of osteosarcoma cells with high metastatic potential isolated from lung metastases of tumor-bearing nude mice, and was labeled with luciferase. The parental cells were the most common Saos2 osteosarcoma cells. Simultaneously culture hFOB cells. The Saos2-lung and hFOB cells grown in logarithmic phase were digested with trypsin and centrifuged at 300g for 5min. After centrifugation, the supernatant was removed, and the cells were resuspended in complete medium and counted individually. The two kinds of cells were seeded into 96-well plates at the number of 5000 / well. The next day after the cells were plated, platycodon saponin D of corresponding concentration was added, and the concentrations of platycodon saponin D were 0, 5, 10 and 20...

Embodiment 2

[0015] Example 2: Implementation steps of the effect of Platycodon saponin D on apoptosis of osteosarcoma cells.

[0016] 1. Apoptosis Induction

[0017] Saos2-lung cells grown in logarithmic phase were taken, digested and centrifuged. After centrifugation, the supernatant was removed, and the cells were resuspended with DMEM complete medium and counted. cells in 2 x 10 5 The number of cells / well was planted in a 6-well plate, the cells were divided into three groups, the concentrations of Platycodon saponin D were 0, 10 and 20 μM, respectively, and three replicate holes were set in each group. After the cells adhered to the wall, platycodon saponin D was added to induce apoptosis, and apoptosis induction was carried out in serum-free medium.

[0018] 2. Apoptosis Detection

[0019] Cells were collected according to the cell subculture method, and EDTA-free trypsin should be used for trypsin. Collect the cell suspension into a flow tube. After centrifuging at 1500rpm for...

Embodiment 3

[0021] Example 3: Implementation steps of the effect of Platycodon saponin D on the growth and metastasis of osteosarcoma in vivo.

[0022] 1. Establishment of osteosarcoma model

[0023] Take the Saos2-lung osteosarcoma cells growing in the logarithmic phase, then digest and centrifuge the cells, resuspend the osteosarcoma cells with PBS solution and count them with a cell counter, observe the viability of the cells with trypan blue staining, and then centrifuge again to pellet the cells . Resuspend the cells in PBS solution to make the cell concentration at least 2×10 8 / ml.

[0024] Subsequently, the osteosarcoma tibial orthotopic model was established with SPF grade 4-week-old nude mice (BALB / c-nu / nu), a total of 20 mice, 5 mice in each group, 4 groups in total. Animal feeding and manipulation were performed in accordance with the requirements of the Animal Ethics Committee of Shanghai Jiaotong University School of Medicine. Anesthetize with 3.5% sodium pentobarbital, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of platycodin D in preparation of a drug for inhibiting tumors. The application of the platycodin D in preparation of the drug for inhibiting tumors has the advantages that the prepared drug for inhibiting tumors can treat tumor patients well, adverse reaction of the patients can be reduced, and a foundation is laid for final healing of the tumor patients.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of platycodon saponin D in the preparation of antitumor drugs. Background technique [0002] Osteosarcoma is a malignant bone tumor that most commonly occurs in adolescents or children under the age of 20. It is the most common bone cancer in children, accounting for about 5% of children's tumors. At present, the main treatment for osteosarcoma is surgery plus postoperative chemotherapy, but chemotherapy drugs often have strong side effects and damage the immune system of the human body. [0003] Therefore, a drug with less side effects, which can not only resist tumors including osteosarcoma, but also reduce the suffering of patients, is of great practical value. Contents of the invention [0004] In order to overcome the deficiencies of the above-mentioned prior art, the present invention provides the application of platycodon saponin, which is characteriz...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P35/00
CPCA61K31/7048
Inventor 汤亭亭韩修国
Owner SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE